search
Back to results

Flaxseed in Controlling Blood Pressure of Patients

Primary Purpose

Hypertension

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Flax Oil Capsule
Placebo Soya Oil Capsule
Sponsored by
B.P. Koirala Institute of Health Sciences
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hypertension

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Age of the patient above 18 years.
  2. Patients who agree to take only physician advised medicine.
  3. Patient who strictly follow diet as advised.
  4. Patients taking single antihypertensive drug with equivalent doses.

Exclusion Criteria:

  1. Patient suffering from serious or recurrent infections.
  2. Pregnancy or breast feeding women, immunodeficiency or HIV patient.
  3. Patient with finding of any mental abnormality, which would interfere with or be affected by the study procedure .
  4. Patient with history of bleeding disorders.
  5. Hypersensitivity reaction or allergy to flaxseed.
  6. History of surgery within past 6 weeks
  7. Patient who do not will to give informed consent.
  8. Alcohol consumption > 30 U/day..
  9. Cigarette smoking > 2 pack/day
  10. Patients taking multiple antihypertensive drugs.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Placebo Comparator

    Arm Label

    500 mg BD Flax Oil Capsule with Antihypertensive drug

    Placebo(Soya Oil) Capsule with Antihypertensive drug

    Arm Description

    Flax Oil Capsule 500 mg twice a day will be administered alongside antihypertensive drug in newly diagnosed hypertensive subjects

    No flax oil capsule,only placebo(soya oil) capsule will be administered alongside equivalent antihypertensive drug in newly diagnosed hypertensive subjects.

    Outcomes

    Primary Outcome Measures

    Flaxseed and Blood Pressure
    Assessing the effects of Flaxseeds in systolic and diastolic blood pressure of patients taking antihypertensive drugs

    Secondary Outcome Measures

    Full Information

    First Posted
    February 9, 2021
    Last Updated
    July 19, 2021
    Sponsor
    B.P. Koirala Institute of Health Sciences
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04759508
    Brief Title
    Flaxseed in Controlling Blood Pressure of Patients
    Official Title
    " Effects of Flaxseed in Blood Pressure of Patients Taking Anti Hypertensive Drugs- A Double Blinded Placebo Controlled Randomized Trial."
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    July 2021
    Overall Recruitment Status
    Unknown status
    Study Start Date
    August 15, 2021 (Anticipated)
    Primary Completion Date
    September 15, 2021 (Anticipated)
    Study Completion Date
    October 15, 2021 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    B.P. Koirala Institute of Health Sciences

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    Hypertension is one of the major risk factor for global mortality. Approximately half of 17 million cardiovascular deaths worldwide are accounted for HTN. Multiple research for cost-effective medication for management of hypertension is going on. An effective alternative to medications in managing hypertension is through lifestyle modifications. Adopting healthy diet is a valuable strategy. Randomized controlled year-long trials observed impressive reductions in blood pressure in patients with hypertension consuming flaxseed daily. Therefore, attention has been garnered for flaxseed as a potentially valuable strategy for the management of hypertension. Double blinded, 2 parallel-group, prospective interventional randomized clinical trial. Investigators are planning to conduct most common and basic method of randomization i.e,"lottery method". This is most popular method and simplest method. In this method both Interventional and Placebo groups are numbered on separate slips of paper of same size, shape and color. They are folded and mixed up in a drum or a box or a container. A blindfold selection is made. Required numbers of slips are selected for the desired sample size. The selection of items thus depends on chance. The respective groups are then allocated in a sequence as Code A and Code B that will be concealed from the researcher (JR) enrolling and assessing participants in sequentially numbered, opaque, sealed and stapled envelope. After getting clearance from IRC, randomization will be done where Interventional and placebo groups will be given Flaxseed Capsule 500 mg and Look-alike(Placebo) Capsule with no therapeutic effect respectively twice a day along with equivalent anti-hypertensive drugs in Medicine OPD,BPKIHS. Blood pressure of all the enrolled subjects will be taken on first day of enrollment before start of intervention. After which subjects will be given respective capsules for first 30 days then follow-up. Assigned with respective arms,subjects will be followed up on 90th day. The proforma which includes patient's sociodemographic data,BP value,Adverse Drug reactions and drug interactions will be filled and data will be entered in MS-Excel subsequently and SPSS v11.5 will be used for further analysis. Investigators are planning to conduct a clinical trial in between 2 groups using power and sample size programme. Investigators need to enroll 36 subjects in each group, to be able to reject null hypothesis that means of two different groups are equal with probability of power 95% and at 5% level of significance. Hence sample size is taken 36 in each group. 10% increment will be done in each group if the subject will not come for follow up. Clinically diagnosed hypertension attending medicine OPD, BPKIHS, Dharan, satisfying the inclusion and exclusion criteria and willing to participate in the study will be enrolled. Prior to the conduction of the study ,ethical clearance will be obtained from the Institutional Review Committee(IRC) of BPKIHS and the clinical trial will be registered. Precaution will also be taken as far as possible to avoid pain and suffering and side effects of the medication to the subjects during the course of the study.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Hypertension

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantInvestigator
    Allocation
    Randomized
    Enrollment
    72 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    500 mg BD Flax Oil Capsule with Antihypertensive drug
    Arm Type
    Active Comparator
    Arm Description
    Flax Oil Capsule 500 mg twice a day will be administered alongside antihypertensive drug in newly diagnosed hypertensive subjects
    Arm Title
    Placebo(Soya Oil) Capsule with Antihypertensive drug
    Arm Type
    Placebo Comparator
    Arm Description
    No flax oil capsule,only placebo(soya oil) capsule will be administered alongside equivalent antihypertensive drug in newly diagnosed hypertensive subjects.
    Intervention Type
    Dietary Supplement
    Intervention Name(s)
    Flax Oil Capsule
    Intervention Description
    Flaxseed with brand name Flax Oil Capsule will be administered to subjects receiving antihypertensives.
    Intervention Type
    Dietary Supplement
    Intervention Name(s)
    Placebo Soya Oil Capsule
    Intervention Description
    Placebo capsule filled with soya oil and inert(inactive) substances will be administered to subjects remaining anti hypertensives.
    Primary Outcome Measure Information:
    Title
    Flaxseed and Blood Pressure
    Description
    Assessing the effects of Flaxseeds in systolic and diastolic blood pressure of patients taking antihypertensive drugs
    Time Frame
    3 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Age of the patient above 18 years. Patients who agree to take only physician advised medicine. Patient who strictly follow diet as advised. Patients taking single antihypertensive drug with equivalent doses. Exclusion Criteria: Patient suffering from serious or recurrent infections. Pregnancy or breast feeding women, immunodeficiency or HIV patient. Patient with finding of any mental abnormality, which would interfere with or be affected by the study procedure . Patient with history of bleeding disorders. Hypersensitivity reaction or allergy to flaxseed. History of surgery within past 6 weeks Patient who do not will to give informed consent. Alcohol consumption > 30 U/day.. Cigarette smoking > 2 pack/day Patients taking multiple antihypertensive drugs.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Rakesh Verma, MBBS, MD
    Phone
    9812560610
    Email
    tipparv@gmail.com
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Rakesh Verma, MBBS, MD
    Organizational Affiliation
    B.P. Koirala Institute of Health Sciences
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    Yes
    IPD Sharing Plan Description
    Individuals enrolled in the respective arms will be shared
    IPD Sharing Time Frame
    Starting February 15,2021
    IPD Sharing Access Criteria
    Assess granted to sponsor, study team and data steward
    Citations:
    PubMed Identifier
    24126178
    Citation
    Rodriguez-Leyva D, Weighell W, Edel AL, LaVallee R, Dibrov E, Pinneker R, Maddaford TG, Ramjiawan B, Aliani M, Guzman R, Pierce GN. Potent antihypertensive action of dietary flaxseed in hypertensive patients. Hypertension. 2013 Dec;62(6):1081-9. doi: 10.1161/HYPERTENSIONAHA.113.02094. Epub 2013 Oct 14.
    Results Reference
    background

    Learn more about this trial

    Flaxseed in Controlling Blood Pressure of Patients

    We'll reach out to this number within 24 hrs